Effects of concomitant aspirin administration on the pharmacokinetics of indomethacin in man
- PMID: 731412
- DOI: 10.1007/BF01062103
Effects of concomitant aspirin administration on the pharmacokinetics of indomethacin in man
Abstract
Ten healthy volunteers each received single and multiple 50-mg doses of indomethacin orally and a single 25-mg dose of [14C]indomethacin intravenously in the absence of and concomitantly with 1200 mg of aspirin as a single dose and in a chronic t.i.d. regimen. Systematic analysis of the data resulted in the isolation and quantification of aspirin's effects on the absorption, distribution, biotransformation, excretion, enterohepatic circulation, and accumulation of indomethacin. The effects of chronic aspirin were to suppress the renal clearance, to increase the biliary clearance, to decrease the efficiency of gastrointestinal absorption, and to enhance the enterohepatic circulation of indomethacin. On concomitant administration of 1200 mg of aspirin t.i.d., mean plasma levels of indomethacin were depressed by 20% after a single oral dose, by a smaller margin after multiple oral doses, and not at all after a single intravenous dose of indomethacin. The mean plasma concentration of orally administered indomethacin was decreased by 8% when given concurrently with a single 1200 mg dose of aspirin. Concomitant chronic therapeutic dosages of indomethacin had no effect on salicylate accumulation from repetitive doses of aspirin.
Similar articles
-
Interaction of indomethacin and acetylsalicylic acid as shown by the serum concentrations of indomethacin and salicylate.Eur J Clin Pharmacol. 1975 Dec 19;9(2-3):199-207. doi: 10.1007/BF00614018. Eur J Clin Pharmacol. 1975. PMID: 1233265
-
Pharmacokinetics of indomethacin.Clin Pharmacol Ther. 1975 Sep;18(3):364-73. doi: 10.1002/cpt1975183364. Clin Pharmacol Ther. 1975. PMID: 1100305 Clinical Trial.
-
Clinical Pharmacokinetics of indomethacin.Clin Pharmacokinet. 1981 Jul-Aug;6(4):245-58. doi: 10.2165/00003088-198106040-00001. Clin Pharmacokinet. 1981. PMID: 7249487
-
Pharmacokinetic overview of indomethacin and sustained-release indomethacin.Am J Med. 1985 Oct 25;79(4C):3-12. doi: 10.1016/0002-9343(85)90510-8. Am J Med. 1985. PMID: 3904441 Review.
-
Clinical pharmacokinetics of the salicylates.Clin Pharmacokinet. 1985 Mar-Apr;10(2):164-77. doi: 10.2165/00003088-198510020-00004. Clin Pharmacokinet. 1985. PMID: 3888490 Review.
Cited by
-
Pharmacokinetic drug interactions with nonsteroidal anti-inflammatory drugs.Clin Pharmacokinet. 1990 Jul;19(1):44-66. doi: 10.2165/00003088-199019010-00004. Clin Pharmacokinet. 1990. PMID: 2199127 Review.
-
Drug interactions involving aspirin (acetylsalicylic acid) and salicylic acid.Clin Pharmacokinet. 1989 Nov;17(5):327-44. doi: 10.2165/00003088-198917050-00003. Clin Pharmacokinet. 1989. PMID: 2573442 Review.
-
Interaction between flurbiprofen and indomethacin in rheumatoid arthritis.Br J Clin Pharmacol. 1982 Mar;13(3):448-51. doi: 10.1111/j.1365-2125.1982.tb01401.x. Br J Clin Pharmacol. 1982. PMID: 7037032 Free PMC article. Clinical Trial. No abstract available.
-
Influence of chronic diflunisal treatment on the plasma levels, metabolism and excretion of indomethacin.Eur J Clin Pharmacol. 1989;37(1):7-15. doi: 10.1007/BF00609416. Eur J Clin Pharmacol. 1989. PMID: 2591467
-
Clinical pharmacokinetics of non-steroidal anti-inflammatory drugs.Clin Pharmacokinet. 1983 Jul-Aug;8(4):297-331. doi: 10.2165/00003088-198308040-00003. Clin Pharmacokinet. 1983. PMID: 6352138 Review.